whitepaper
Review: Protein misfolding in neurodegenerative diseases
Peer-reviewed publication on new strategies to target misfolded protein aggregates at various steps of protein production and processing...
List view / Grid view
Translational Science
news
Charles River Laboratories announces updates to oncology business
Charles River Laboratories International, Inc. (NYSE: CRL) recently announced updates to its expanding oncology discovery business, including significant additions to its online Tumor Model Compendium...
news
Charles River Laboratories announces launch of triple-immunodeficient mouse model for oncology research
Charles River Laboratories International, Inc. (NYSE: CRL), a leading early-stage contract research organization (CRO), announced the North American launch of its triple-immunodeficient mouse model, known as the NCG model...
webinar
Novel readouts for neuropathic pain models
3 April 2017 | By Charles River
This webinar reviews standard neuropathic pain models and readouts and will include fine motor kinematic analysis to highlight gait changes...
news
Quotient Clinical announces second US acquisition: QS Pharma
Quotient Clinical announces that it has acquired QS Pharma from Charles River Laboratories International, Inc...
news
Quotient Clinical acquires SeaView Research, the specialist clinical pharmacology business
Quotient Clinical announces that it has acquired SeaView Research, expanding its operations into the USA...
news
Lorenz Mayr joins Drug Discovery 2017 speaker lineup
Lorenz Mayr, esteemed Vice President and Global Head of Biological Reagents and Assay Development at AstraZeneca will be joining the expert speaker lineup for the launch conference on Drug Discovery. The event takes place on 27 and 28 April 2017 in London.
product
ProteinSimple Milo
12 January 2017 | By ProteinSimple
Single-Cell Western system capable of analysing protein expression in ~1,000 single-cells in parallel to unlock heterogeneity...
webinar
New strategy to identify small molecule therapies
1 December 2016 | By Charles River
This webinar details a successful new strategy to identify small molecule therapies to treat protein-destabilizing monogenic disorders...
product
EMD Millipore: Verifi(Ab)le – Neuroscience Antibodies
28 June 2016 | By Merck KGaA
EMD Millipore is continually developing and refining tools and technologies for the study of neuroscience. Researchers can count on our comprehensive portfolio of dependable, high-quality solutions for elucidating questions related to neuroscience...
article
Translating stem cell biology into drug discovery
Pluripotent stem cell research has made extraordinary progress over the past decade. The robustness of nuclear reprogramming of somatic cells into induced pluripotent stem cells (iPSCs) has created entirely novel opportunities for drug discovery and personalised regenerative medicine...
product
EMD Millipore: Repeat(Ab)le – Epigenetics Antibodies
15 June 2016 | By Merck KGaA
We offer an extensive, focused portfolio of antibodies and immunoassays, including validated antibodies for effective immunoprecipitation of chromatin, RNA-binding proteins, modified histones, and transcriptional proteins...
news
Quotient Clinical extends spray drying capabilities for poorly soluble molecules
13 June 2016 | By Quotient Clinical
Quotient Clinical has expanded its clinical spray drying capability through the acquisition of a Niro Mobile Minor™ Spray Dryer...
product
EMD Millipore: Depend(Ab)le – Stem Cell Antibodies
2 June 2016 | By Merck KGaA
EMD Millipore’s extensive portfolio of validated antibodies help unravel the complexities of stem cell research...
whitepaper
Whitepaper: Single-tube DNA purification and cloning using ultrafiltration devices
Traditional methods for subcloning DNA fragments or shuttling sequences between vectors involve the ligation of restriction digest fragments...
